These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36440784)

  • 1. [Evaluation of the efficacy and safety of Dolocox in patients with nonspecific back].
    Yakupov EZ; Troshina YV; Trutneva NK; Gainutdinova RR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):94-97. PubMed ID: 36440784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of nonsteroidal anti-inflammatory drugs on the indicators of cardiovascular risk in patients with acute nonspecific back pain].
    Zolotovskaya IA; Davydkin IL
    Ter Arkh; 2015; 87(12):18-25. PubMed ID: 26978413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the efficacy and safety of the neuroprotective complex Neurouridin in patients with back pain].
    Yakupov EZ; Troshina YV; Gainutdinova RR; Kashapova AO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(6):46-51. PubMed ID: 34283529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study.
    Zerbini C; Ozturk ZE; Grifka J; Maini M; Nilganuwong S; Morales R; Hupli M; Shivaprakash M; Giezek H;
    Curr Med Res Opin; 2005 Dec; 21(12):2037-49. PubMed ID: 16368055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The results of a study on the safety of the dietary supplement neurouridine in patients with nonspecific low back pain (MULTINEURO-2)].
    Yakupov EZ; Troshina JV; Gainutdinova RR; Kashapova AO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):52-56. PubMed ID: 33834718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The assessment of efficacy and tolerability of the complex therapy of low back pain].
    Shavlovskaya OA; Romanov ID
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7):63-67. PubMed ID: 32790978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study.
    Perrot S; Krause D; Crozes P; Naïm C;
    Clin Ther; 2006 Oct; 28(10):1592-606. PubMed ID: 17157115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.
    Coats TL; Borenstein DG; Nangia NK; Brown MT
    Clin Ther; 2004 Aug; 26(8):1249-60. PubMed ID: 15476906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The possibilities of using chondroitin sulfate in patients with chronic back pain].
    Istomina EV; Shikhkerimov RK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):12-15. PubMed ID: 31089089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs for acute low back pain.
    van der Gaag WH; Roelofs PD; Enthoven WT; van Tulder MW; Koes BW
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013581. PubMed ID: 32297973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a randomized double blind parallel study on the efficacy and safety of tolpersione in patients with acute nonspecific low back pain].
    Kukushkin ML; Brylev LV; Laskov VB; Makarov NS; Pizova NV; Sokov EL; Chefranova ZY; Sholomov II; Guekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):69-78. PubMed ID: 29265090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain.
    Innes GD; Croskerry P; Worthington J; Beveridge R; Jones D
    J Emerg Med; 1998; 16(4):549-56. PubMed ID: 9696169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine.
    Deer TR; Caraway DL; Kim CK; Dempsey CD; Stewart CD; McNeil KF
    Spine J; 2002; 2(4):274-8. PubMed ID: 14589479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127).
    Wallace M; Skowronski R; Khanna S; Tudor IC; Thipphawong J
    Curr Med Res Opin; 2007 May; 23(5):981-9. PubMed ID: 17519065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drugs for chronic low back pain.
    Enthoven WT; Roelofs PD; Deyo RA; van Tulder MW; Koes BW
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD012087. PubMed ID: 26863524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To evaluate efficacy and safety of fixed dose combination of aceclofenac + paracetamol + thiocolchicoside (acenac-MR) in the treatment of acute low back pain.
    Lahoti G
    J Indian Med Assoc; 2012 Jan; 110(1):56-8. PubMed ID: 23029837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.